Boyle Scott N — SEC Form 4 filings
SEC reporting owner CIK 1913897. 6 Form 4 filings on record with FilingPulse; latest filed 2026-02-18.
Transaction summary — filings shown
Covers all 6 filings on record, filed 2024-02-15 to 2026-02-18. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 2 legs across 1 filing — 1,159 shares, $3,651 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 20.
- Largest priced transaction: sale of 669 shares @ $3.15 ($2,107) in C4 Therapeutics, Inc., filed 2025-02-18.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| C4 Therapeutics, Inc. (CCCC) | Chief Business Officer | 6 | — | 2 legs · 1,159 sh · $3,651 | 20 |
Form 4 filings — Boyle Scott N
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-02-18 | 4 | C4 Therapeutics, Inc. (CCCC) | Grant/award (A): 200,000 @ $0 · Option exercise (M): 5,000 @ $0 · Tax withholding (F): 1,735 @ $1.89 · Option exercise (M): 20,950 @ $0 · Tax withholding (F): 7,269 @ $1.89 | EDGAR |
| 2025-02-18 | 4 | C4 Therapeutics, Inc. (CCCC) | Tax withholding (F): 1,735 @ $3.20 · Grant/award (A): 56,500 @ $0 · Sale (S): 490 @ $3.15 · Tax withholding (F): 2,368 @ $3.18 · Sale (S): 669 @ $3.15 · Grant/award (A): 84,700 (derivative) @ $0 | EDGAR |
| 2024-11-12 | 4 | C4 Therapeutics, Inc. (CCCC) | Option exercise (M): 3,750 · Tax withholding (F): 1,102 @ $6.04 · Option exercise (M): 3,750 (derivative) @ $0 | EDGAR |
| 2024-09-17 | 4 | C4 Therapeutics, Inc. (CCCC) | Option exercise (M): 2,250 · Tax withholding (F): 661 @ $6.36 · Option exercise (M): 2,250 (derivative) @ $0 | EDGAR |
| 2024-03-08 | 4 | C4 Therapeutics, Inc. (CCCC) | Disposition to issuer (D): 115,000 (derivative) @ $0 · Grant/award (A): 115,000 (derivative) @ $0 | EDGAR |
| 2024-02-15 | 4 | C4 Therapeutics, Inc. (CCCC) | Tax withholding (F): 1,735 @ $6.53 · Grant/award (A): 27,300 @ $0 · Grant/award (A): 122,800 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1913897 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →